<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107697"><dct:format>application/xml</dct:format><dct:title>Data on synthesis and structure&#x2013;activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes</dct:title><dct:creator>Seiji Komeda</dct:creator><dct:creator>Hiroki Yoneyama</dct:creator><dct:creator>Masako Uemura</dct:creator><dct:creator>Takahiro Tsuchiya</dct:creator><dct:creator>Miyuu Hoshiyama</dct:creator><dct:creator>Tomoya Sakazaki</dct:creator><dct:creator>Keiichi Hiramoto</dct:creator><dct:creator>Shinya Harusawa</dct:creator><dct:subject><rdf:Bag><rdf:li>Platinum</rdf:li><rdf:li>Tetrazole</rdf:li><rdf:li>Cancer</rdf:li><rdf:li>NMR</rdf:li><rdf:li>MS</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 40 (2022). doi:10.1016/j.dib.2021.107697</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 The Authors. Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>40</prism:volume><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107697</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107697</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107697</dct:identifier><bam:articleNumber>107697</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-08T12:56:24Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.2</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107697</ja:aid><ce:article-number>107697</ce:article-number><ce:pii>S2352-3409(21)00972-0</ce:pii><ce:doi>10.1016/j.dib.2021.107697</ce:doi><ce:document-thread><ce:refers-to-document id="ref0001"><ce:pii>S0162-0134(18)30631-7</ce:pii><ce:doi>10.1016/j.jinorgbio.2018.12.009</ce:doi></ce:refers-to-document></ce:document-thread><ce:copyright type="other" year="2021">The Authors</ce:copyright></ja:item-info><ja:head><ce:dochead id="dchd0001"><ce:textfn id="dhtxt0001">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">Data on synthesis and structure&#x2013;activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921009720-fc385d0157fa58f3f1fa54c39ab74882" orcid="0000-0001-5532-3251"><ce:given-name>Seiji</ce:given-name><ce:surname>Komeda</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:komedas@suzuka-u.ac.jp">komedas@suzuka-u.ac.jp</ce:e-address></ce:author><ce:author id="au0002" author-id="S2352340921009720-b7d1108c5d1d1fcfb16f9c5e13fbf227"><ce:given-name>Hiroki</ce:given-name><ce:surname>Yoneyama</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921009720-eaf7376da51c58f8008b85af02eab24b"><ce:given-name>Masako</ce:given-name><ce:surname>Uemura</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2352340921009720-f491e978b7f44a76858d5b1dfce9b005"><ce:given-name>Takahiro</ce:given-name><ce:surname>Tsuchiya</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2352340921009720-f3f1cf62f0e6620c2eca300a3a8ff27b"><ce:given-name>Miyuu</ce:given-name><ce:surname>Hoshiyama</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2352340921009720-f2313bd255c3c470dff26afde3f552da"><ce:given-name>Tomoya</ce:given-name><ce:surname>Sakazaki</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0007" author-id="S2352340921009720-691975720cfe65a7842affe1b6a380ea"><ce:given-name>Keiichi</ce:given-name><ce:surname>Hiramoto</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0008" author-id="S2352340921009720-3e05cd61019d1428da878241a135cda3"><ce:given-name>Shinya</ce:given-name><ce:surname>Harusawa</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921009720-3b920e34e7c23bc98d77ca44556843a6"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan</ce:textfn><sa:affiliation><sa:organization>Faculty of Pharmaceutical Sciences</sa:organization><sa:organization>Suzuka University of Medical Science</sa:organization><sa:city>Suzuka</sa:city><sa:state>Mie</sa:state><sa:postal-code>513-8670</sa:postal-code><sa:country>Japan</sa:country></sa:affiliation><ce:source-text id="staff0001">aFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921009720-797417cdfcb5ae92857bf2dabcd7b96b"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Department of Pharmaceutical Organic Chemistry, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-1094, Japan</ce:textfn><sa:affiliation><sa:organization>Department of Pharmaceutical Organic Chemistry</sa:organization><sa:organization>Osaka Medical and Pharmaceutical University</sa:organization><sa:city>Takatsuki</sa:city><sa:state>Osaka</sa:state><sa:postal-code>569-1094</sa:postal-code><sa:country>Japan</sa:country></sa:affiliation><ce:source-text id="staff0002">bDepartment of Pharmaceutical Organic Chemistry, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-1094, Japan</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="10" month="9" year="2021"/><ce:date-revised day="7" month="12" year="2021"/><ce:date-accepted day="8" month="12" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara003" view="all">In this data file, the synthetic procedures for the preparation of a series of anticancer tetrazolato-bridged dinuclear platinum(II) complexes ([{<ce:italic>cis</ce:italic>-Pt(NH<ce:inf loc="post">3</ce:inf>)<ce:inf loc="post">2</ce:inf>}<ce:inf loc="post">2</ce:inf>(&#x03bc;-OH)(&#x03bc;-5-R-tetrazolato-<ce:italic>N</ce:italic>2,<ce:italic>N</ce:italic>3)]<ce:sup loc="post">n+</ce:sup> (<ce:italic>n</ce:italic>&#160;=&#160;1 or 2, tetrazolato-bridged complexes)) and of the bridging ligands of 5-substituted 1<ce:italic>H</ce:italic>-tetrazoles (5-R-1<ce:italic>H</ce:italic>-tetrazoles) are described. These compounds were characterized by <ce:sup loc="post">1</ce:sup>H-, <ce:sup loc="post">13</ce:sup>C-, <ce:sup loc="post">19</ce:sup>F- and <ce:sup loc="post">195</ce:sup>Pt-NMR spectroscopy and mass spectrometry.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Platinum</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Tetrazole</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Cancer</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">NMR</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">MS</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
